Followers | 17 |
Posts | 1413 |
Boards Moderated | 0 |
Alias Born | 12/19/2017 |
Friday, February 12, 2021 11:46:27 AM
Recent MNPR News
- Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting • GlobeNewswire Inc. • 04/18/2024 12:00:00 PM
- Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings • GlobeNewswire Inc. • 04/16/2024 12:00:00 PM
- Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients • GlobeNewswire Inc. • 04/10/2024 12:00:22 PM
- Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments • GlobeNewswire Inc. • 03/28/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 01:30:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 12:00:14 PM
- Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program • GlobeNewswire Inc. • 03/05/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 06:45:43 PM
- Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial • GlobeNewswire Inc. • 02/27/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 11:59:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 12:00:22 PM
- Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers • GlobeNewswire Inc. • 02/22/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 01:00:15 PM
- Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers • GlobeNewswire Inc. • 02/20/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:39:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:36:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 12:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 12:00:13 PM
- Monopar Therapeutics Reports Third Quarter 2023 Financial Results and Recent Developments • GlobeNewswire Inc. • 11/09/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 11:00:14 AM
- Monopar Presents Data Showing Tumor Reduction Benefit of Camsirubicin from Ongoing Phase 1b at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting • GlobeNewswire Inc. • 11/01/2023 11:00:00 AM
- Monopar to Participate in the Roth MKM 2023 Healthcare Opportunities Conference • GlobeNewswire Inc. • 10/10/2023 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 11:37:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 11:30:33 PM
- Monopar to Participate in the H.C. Wainwright 25th Annual Global Investment Conference • GlobeNewswire Inc. • 09/05/2023 11:00:00 AM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM